Welcome
Select Area of Interest
Blank Space
Choose topic:
FAQs
Epidemiology
Pathology
Diagnosis
Control
Prevention
Herd/Flock Management
Laws & Regulations
True Cases & Stories
Gallery Graphics
Line
General Information
Glossary
History
Biology of Ml. Paratuberculosis
Antimicrobial Therapy
Zoonotic Potential
Handouts/Brochures
Links

Testing Services
Guestbook
Sponsors & Credits
Ask the Expert
Site Map
Search the Site
Home
Blank Space
HISTORY
JOHNE'S INFORMATION CENTER - University of Wisconsin Ñ School of Veterinary Medicine



Bar
Thursday, August 14, 2014
Clinical trial for treating Crohn's disease with anti-MAP antibiotics

RedHill BioPharma has initiated a first Phase III clinical trial with RHB-104 (antibiotics directed against MAP) for Crohn’s Disease in North America and Israel. The link provides more information, including a list of clinical centers recruiting patients for the study in the U.S., Canada, and Israel.

Clinical trial detail on ClinicalTrials.gov website